本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

天演药业

1.69
-0.3200-15.92%
盘后1.820.1300+7.69%19:43 EDT
成交量:41.28万
成交额:86.75万
市值:7,965.18万
市盈率:-2.63
高:2.50
开:2.05
低:1.65
收:2.01
52周最高:3.58
52周最低:1.33
股本:4,713.13万
流通股本:1,024.34万
量比:5.87
换手率:4.03%
股息:- -
股息率:- -
每股收益(TTM):-0.6428
每股收益(LYR):-0.7423
净资产收益率:-63.26%
总资产收益率:-24.89%
市净率:2.10
市盈率(LYR):-2.28

数据加载中...

2025/05/28

SEC问询函

Form CORRESP - Correspondence
2025/05/23

SEC问询函

Form CORRESP - Correspondence
2025/03/24

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

SEC问询函

Form CORRESP - Correspondence
2023/06/16

SEC问询函

Form CORRESP - Correspondence
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/13

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/26

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals